| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $674.6M | -3.1% | +8.7% |
| Cost of Revenue | $178.4M | -8.9% | +6.1% |
| R&D Expense | $98.8M | -13.7% | -0.4% |
| SG&A Expense | $91.2M | +409.5% | +18.8% |
| Operating Income | $98.4M | -10.3% | +0.9% |
| Pre-tax Income | $58.1M | +28.8% | -8.8% |
| Income Tax | $19.0M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $587.9M | +17.4% | -48.7% |
| Accounts Receivable | $168.0M | -13.4% | +5.3% |
| Current Assets | $993.2M | +8.4% | -32.4% |
| Total Assets | $3.69B | +1.4% | +15.7% |
| Current Liabilities | $703.1M | +5.8% | +55.5% |
| Long-term Debt |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $281.8M | — | — |
| Capital Expenditures | $25.6M | — | — |
| Investing Cash Flow | -$115.8M | — | — |
| Financing Cash Flow | -$145.2M | — | — |
| Free Cash Flow | $256.2M | — | — |
| +59.7% |
| -22.1% |
| Net Income | $39.1M | +17.8% | -0.5% |
| EPS (Basic) | $0.11 | +22.2% | +0.0% |
| EPS (Diluted) | $0.11 | +22.2% | +0.0% |
| $2.39B |
| -0.1% |
| -0.5% |
| Total Liabilities | $3.76B | +1.0% | +14.5% |
| Stockholders' Equity | -$74.8M | +14.8% | +23.7% |